Rizatriptan Benzoate
Product Images NDC 53002-3713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 53002-3713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530023713)

FDA Label Image

Rizatriptan-fig-1 (Rizatriptan Fig 1)

Rizatriptan-fig-1 (Rizatriptan Fig 1)
This is a graph showing the probability of response to Rizatriptan Benzoate at 5mg and 10mg doses and a Placebo. The X-axis represents the Hours Post-Dose and the Y-axis represents the Probability of Response. The graph indicates that Rizatriptan Benzoate at 5mg and 10mg doses has a higher probability of response than the Placebo. The text is readable.*
FDA Label Image

Rizatriptan-fig-2 (Rizatriptan Fig 2)

Rizatriptan-fig-2 (Rizatriptan Fig 2)
This appears to be a graph displaying estimated probabilities of remedication or rescue after taking different doses of rizatriptan benzoate, a medication used to treat migraines. The graph shows that the probability of remedication or rescue is 100% for both 5 mg and 10 mg doses, represented by the larger bars on the graph. The smaller bars represent a placebo. The x-axis shows the number of hours post-dose and the y-axis represents percentage probability.*
FDA Label Image

Rizatriptan-fig-5 (Rizatriptan Fig 5)

FDA Label Image

Rizatriptan-structure (Rizatriptan Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.